Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 27

1.

Cause of Death and Predictors of All-Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF.

Pokorney SD, Piccini JP, Stevens SR, Patel MR, Pieper KS, Halperin JL, Breithardt G, Singer DE, Hankey GJ, Hacke W, Becker RC, Berkowitz SD, Nessel CC, Mahaffey KW, Fox KA, Califf RM; ROCKET AF Steering Committee & Investigators; ROCKET AF Steering Committee Investigators.

J Am Heart Assoc. 2016 Mar 8;5(3):e002197. doi: 10.1161/JAHA.115.002197.

2.

Inducibility of ventricular fibrillation during mild therapeutic hypothermia: electrophysiological study in a swine model.

Kudlicka J, Mlcek M, Belohlavek J, Hala P, Lacko S, Janak D, Havranek S, Malik J, Janota T, Ostadal P, Neuzil P, Kittnar O.

J Transl Med. 2015 Feb 22;13:72. doi: 10.1186/s12967-015-0429-9.

3.

Long-term use of ticagrelor in patients with prior myocardial infarction.

Bonaca MP, Bhatt DL, Cohen M, Steg PG, Storey RF, Jensen EC, Magnani G, Bansilal S, Fish MP, Im K, Bengtsson O, Oude Ophuis T, Budaj A, Theroux P, Ruda M, Hamm C, Goto S, Spinar J, Nicolau JC, Kiss RG, Murphy SA, Wiviott SD, Held P, Braunwald E, Sabatine MS; PEGASUS-TIMI 54 Steering Committee and Investigators.

N Engl J Med. 2015 May 7;372(19):1791-800. doi: 10.1056/NEJMoa1500857. Epub 2015 Mar 14.

4.

Efficacy and safety of rivaroxaban compared with warfarin among elderly patients with nonvalvular atrial fibrillation in the Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF).

Halperin JL, Hankey GJ, Wojdyla DM, Piccini JP, Lokhnygina Y, Patel MR, Breithardt G, Singer DE, Becker RC, Hacke W, Paolini JF, Nessel CC, Mahaffey KW, Califf RM, Fox KA; ROCKET AF Steering Committee and Investigators.

Circulation. 2014 Jul 8;130(2):138-46. doi: 10.1161/CIRCULATIONAHA.113.005008. Epub 2014 Jun 3.

5.

Reperfusion therapy for ST elevation acute myocardial infarction 2010/2011: current status in 37 ESC countries.

Kristensen SD, Laut KG, Fajadet J, Kaifoszova Z, Kala P, Di Mario C, Wijns W, Clemmensen P, Agladze V, Antoniades L, Alhabib KF, De Boer MJ, Claeys MJ, Deleanu D, Dudek D, Erglis A, Gilard M, Goktekin O, Guagliumi G, Gudnason T, Hansen KW, Huber K, James S, Janota T, Jennings S, Kajander O, Kanakakis J, Karamfiloff KK, Kedev S, Kornowski R, Ludman PF, Merkely B, Milicic D, Najafov R, Nicolini FA, Noč M, Ostojic M, Pereira H, Radovanovic D, Sabaté M, Sobhy M, Sokolov M, Studencan M, Terzic I, Wahler S, Widimsky P; European Association for Percutaneous Cardiovascular Interventions.

Eur Heart J. 2014 Aug 1;35(29):1957-70. doi: 10.1093/eurheartj/eht529. Epub 2014 Jan 12. Erratum in: Eur Heart J. 2014 Oct 7;35(38):2697.

PMID:
24419804
6.

Prasugrel versus clopidogrel for acute coronary syndromes without revascularization.

Roe MT, Armstrong PW, Fox KA, White HD, Prabhakaran D, Goodman SG, Cornel JH, Bhatt DL, Clemmensen P, Martinez F, Ardissino D, Nicolau JC, Boden WE, Gurbel PA, Ruzyllo W, Dalby AJ, McGuire DK, Leiva-Pons JL, Parkhomenko A, Gottlieb S, Topacio GO, Hamm C, Pavlides G, Goudev AR, Oto A, Tseng CD, Merkely B, Gasparovic V, Corbalan R, Cinteză M, McLendon RC, Winters KJ, Brown EB, Lokhnygina Y, Aylward PE, Huber K, Hochman JS, Ohman EM; TRILOGY ACS Investigators.

N Engl J Med. 2012 Oct 4;367(14):1297-309. doi: 10.1056/NEJMoa1205512. Epub 2012 Aug 25.

7.

Left ventricle remodeling in men with moderate to severe volume-dependent hypertension.

Indra T, Holaj R, Zelinka T, Petrák O, Strauch B, Rosa J, Somlóová Z, Malík J, Janota T, Hradec J, Widimsky J Jr.

J Renin Angiotensin Aldosterone Syst. 2012 Dec;13(4):426-34. doi: 10.1177/1470320312446240. Epub 2012 May 29.

PMID:
22645061
8.

Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF.

Hankey GJ, Patel MR, Stevens SR, Becker RC, Breithardt G, Carolei A, Diener HC, Donnan GA, Halperin JL, Mahaffey KW, Mas JL, Massaro A, Norrving B, Nessel CC, Paolini JF, Roine RO, Singer DE, Wong L, Califf RM, Fox KA, Hacke W; ROCKET AF Steering Committee Investigators.

Lancet Neurol. 2012 Apr;11(4):315-22. doi: 10.1016/S1474-4422(12)70042-X. Epub 2012 Mar 7.

PMID:
22402056
9.

Arteriovenous fistula after femoral artery puncture leading to pulmonary edema: the role of ultrasonography.

Malík J, Holaj R, Krupičková Z, Janota T.

Prague Med Rep. 2012;113(1):49-52.

PMID:
22373805
10.

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.

Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W, Breithardt G, Halperin JL, Hankey GJ, Piccini JP, Becker RC, Nessel CC, Paolini JF, Berkowitz SD, Fox KA, Califf RM; ROCKET AF Investigators.

N Engl J Med. 2011 Sep 8;365(10):883-91. doi: 10.1056/NEJMoa1009638. Epub 2011 Aug 10.

11.

Low-dose vs standard-dose unfractionated heparin for percutaneous coronary intervention in acute coronary syndromes treated with fondaparinux: the FUTURA/OASIS-8 randomized trial.

FUTURA/OASIS-8 Trial Group, Steg PG, Jolly SS, Mehta SR, Afzal R, Xavier D, Rupprecht HJ, López-Sendón JL, Budaj A, Diaz R, Avezum A, Widimsky P, Rao SV, Chrolavicius S, Meeks B, Joyner C, Pogue J, Yusuf S.

JAMA. 2010 Sep 22;304(12):1339-49. doi: 10.1001/jama.2010.1320. Epub 2010 Aug 31.

PMID:
20805623
12.

Effect of short-term maximal exercise on BNP plasma levels in healthy individuals.

Krupicka J, Janota T, Kasalová Z, Hradec J.

Physiol Res. 2010;59(4):625-8. Epub 2009 Nov 20.

13.

[Will the therapy of chronic heart failure be guided by plasma levels of natriuretic peptides?].

Hradec J, Krupicka J, Janota T.

Cas Lek Cesk. 2009;148(8):383-8. Review. Czech.

PMID:
19899725
14.

[Hypertensive crisis--the present view].

Janota T.

Cas Lek Cesk. 2009;148(8):370-3. Review. Czech.

PMID:
19899722
15.

Surprisingly delayed escalation of severe verapamil poisoning.

Tuka V, Ricarova B, Janota T, Malik J, Kotrlikova E.

Eur J Emerg Med. 2009 Apr;16(2):100-2. doi: 10.1097/MEJ.0b013e32830a997c.

PMID:
19194302
16.

Natriuretic peptides - physiology, pathophysiology and clinical use in heart failure.

Krupicka J, Janota T, Kasalová Z, Hradec J.

Physiol Res. 2009;58(2):171-7. Epub 2008 Apr 1. Review.

17.

Impact of essential hypertension and primary aldosteronism on plasma brain natriuretic peptide concentration.

Jakubik P, Janota T, Widimsky J Jr, Zelinka T, Strauch B, Petrak O, Benakova H, Bezdickova D, Wichterle D, Zima T, Hradec J.

Blood Press. 2006;15(5):302-7.

PMID:
17380848
18.

Regression of acromegalic left ventricular hypertrophy after lanreotide (a slow-release somatostatin analog).

Hradec J, Kral J, Janota T, Krsek M, Hana V, Marek J, Malik M.

Am J Cardiol. 1999 May 15;83(10):1506-9, A8.

PMID:
10335774
19.

Autonomic modulation of ventricular rate in atrial fibrillation.

Nagayoshi H, Janota T, Hnatkova K, Camm AJ, Malik M.

Am J Physiol. 1997 Apr;272(4 Pt 2):H1643-9.

PMID:
9139946
20.

Changes of QT intervals associated with postural change in patients with chronic atrial fibrillation.

Malik M, Janota T, Nagayoshi H, Hnatkova K, Camm AJ.

Pacing Clin Electrophysiol. 1996 Apr;19(4 Pt 1):490-5.

PMID:
8848398

Supplemental Content

Loading ...
Support Center